- Home
- Advocacy
- Latest News and Practice Data
- New: Pathology MVP added to 2026 QPP
For the first time, MIPS Value Pathways (MVPs) will include a pathology-specific track in the 2026 Quality Payment Program (QPP). CMS continues to state that MVPs will eventually be the only way to report MIPS.
- Details: It includes publicly-available clinical quality measures, measures from our Pathologists Quality Registry, and other private measures. The MVP also includes some activities that pathologists are not eligible for.
- Contact: For information about reporting the Pathology MVP, email us at mips@cap.org.
Other 2026 QPP changes: The proposed rulemaking keeps the performance threshold at 75 points for 2026 through 2028 and the data completeness threshold at 75% of all eligible cases.
- Impact on pathologists: The CAP opposes any further increases to the performance threshold or data completeness requirement, and has advocated in the past for lowering both.
- Stability: CMS has not proposed adding or removing any quality measures from the Pathology Specialty Measure Set. A stable measure set helps practices know what to expect in the following year.
- Removal of Improvement Activities: As previously finalized, for 2026, CMS will remove some of the most highly used Improvement Activities. Practices will need to find alternatives.
Digital measurement: CMS seeks input on driving the transition to digital quality measurement.
- The CAP supports digital measurement as long as it reduces burdens and unnecessary system updates but urges caution against moving to an immature data standard.
CAP support: Practices are encouraged to review scoring changes and contact CAP for guidance on high-scoring measures, email us at mips@cap.org.